Skip to content
Decision-ready map
• Physics: chromophore absorption + thermal relaxation
• Equity: melanin changes energy deposition and heating
• Evidence: cohort signals + complication reviews + dosing concepts
• Mitigation: dose discipline + stop rules + transparent reporting
(1) What it is
Thermal injury disparities in light-based therapy form a high-impact teaching case at the intersection of physics and public benefit. The core concept is selective absorption: tissue chromophores (melanin, hemoglobin, water) absorb differently across wavelengths, and absorbed energy can become heat. The translational lesson is that clinical benefit requires a narrow window: enough dose to help, not so much that it harms—and that this window can vary across individuals.
(2) Who it helps
This brief supports educators in medicine, dentistry, physiotherapy, nursing, biomedical engineering, and science communication who want to teach responsible innovation and equity-by-design using real evidence.
(3) What evidence exists
Use the 2025 cohort study as a concrete primary source linking darker skin color with higher photosensitivity and greater thermal injury odds under a PBM protocol (https://doi.org/10.1111/phpp.70042). Then broaden with reviews on complications in skin of color (https://doi.org/10.4103/ijdvl.IJDVL_88_17) and IPL complication mechanisms and prevention (https://doi.org/10.1002/der2.57). Introduce MED as an operational UV dosing concept and show that MED correlates with Fitzpatrick type (https://doi.org/10.1016/j.ad.2019.12.003). Finally, use PBM dosimetry discussions to teach that “dose” must be fully specified (https://doi.org/10.21037/atm.2016.05.34) and link to FDA guidance as an example of governance (FDA webpage).
(4) Translation barriers
Educational barriers include oversimplification (e.g., ‘darker skin just needs higher dose’) and confusion between race, skin tone, and phototype. Learners may see “J/cm²” but not understand how spot size, distance, beam profile, and duty cycle change delivered irradiance and heating. Another barrier is treating adverse events as operator mistakes rather than predictable system interactions.
(5) Equity/safety checks
Teach a checklist: identify dominant chromophores; map where heat is generated; specify parameters; require stratified safety evidence; define stop rules; and report incidents. Emphasize transparent parameter reporting and safe fallback behaviors (stop, cool, reassess).
(6) Decision questions
• What competency is the learning goal: physics, dosing literacy, consent communication, or governance?
• Are students required to translate evidence into a safer protocol and audit plan?
• Do materials teach mitigation pathways, not only the problem?
(7) Practical next steps
Create a 1–2 session module: paper discussion (de Brito 2025) + parameter mapping exercise + procurement/labeling role play using FDA guidance. Add a short lab where learners compute delivered dose under different spot sizes/time and discuss how melanin absorption could shift risk. Require an ‘equity-by-design’ appendix in student projects.
(8) References
https://doi.org/10.1111/phpp.70042
https://doi.org/10.4103/ijdvl.IJDVL_88_17
https://doi.org/10.1002/der2.57
https://doi.org/10.1016/j.ad.2019.12.003
https://doi.org/10.21037/atm.2016.05.34
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/photobiomodulation-pbm-devices-premarket-notification-510k-submissions